{"id":"premixed-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL1201631","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Premixed insulin formulations contain a fixed ratio of short-acting (or rapid-acting) insulin and intermediate-acting insulin in a single injection. The rapid-acting component begins working within minutes to control postprandial (after-meal) glucose spikes, while the intermediate-acting component provides basal insulin coverage over several hours. This combination reduces the need for multiple daily injections while maintaining glycemic control.","oneSentence":"Premixed insulin combines rapid-acting and intermediate-acting insulin to provide both immediate and sustained blood glucose control.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:02:24.004Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT07387003","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Gan & Lee Pharmaceuticals.","startDate":"2026-03-20","conditions":"Type 2 Diabetes (T2DM)","enrollment":300},{"nctId":"NCT07307235","phase":"PHASE4","title":"Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2025-12-15","conditions":"Type 2 Diabetes","enrollment":1316},{"nctId":"NCT05614089","phase":"PHASE4","title":"Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings","status":"COMPLETED","sponsor":"Jing Luo","startDate":"2023-03-15","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":400},{"nctId":"NCT06854861","phase":"PHASE1, PHASE2","title":"Premixed Glucagon/Insulin Solution for Faster Insulin Absorption in Type 1 Diabetes","status":"SUSPENDED","sponsor":"St. Olavs Hospital","startDate":"2025-04-01","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT06925334","phase":"PHASE4","title":"A Study Comparing Degu Insulin Liraglutide Injection With Premixed Insulin on the Prognosis of Diabetes Mellitus","status":"ENROLLING_BY_INVITATION","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2024-05-20","conditions":"Type 2 Diabetic Patients","enrollment":170},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT06528002","phase":"","title":"Hybrid Method Between Low-ratio Premixed Insulin and Short Acting Insulin in Fasting Type 2 Diabetic Patients in Ramadan","status":"COMPLETED","sponsor":"Sohag University","startDate":"2024-03-01","conditions":"Continous Blood Glucose Monitoring, Calculation of Body Mass Index, Measurment of Blood Pressure","enrollment":45},{"nctId":"NCT06558708","phase":"PHASE2","title":"A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD","status":"RECRUITING","sponsor":"Gan and Lee Pharmaceuticals, USA","startDate":"2024-06-28","conditions":"Type 2 Diabetes","enrollment":60},{"nctId":"NCT06408532","phase":"PHASE4","title":"The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-04-30","conditions":"Diabetes Mellitus, Type 2","enrollment":256},{"nctId":"NCT03700801","phase":"PHASE4","title":"Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy","status":"COMPLETED","sponsor":"Zhujiang Hospital","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus","enrollment":130},{"nctId":"NCT04833413","phase":"","title":"Regimen Switch After Intensive Insulin Therapy","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2021-04-15","conditions":"Insulin","enrollment":1000},{"nctId":"NCT05545800","phase":"PHASE3","title":"Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy","status":"UNKNOWN","sponsor":"Xiangya Hospital of Central South University","startDate":"2022-09-01","conditions":"Type 2 Diabetes Mellitus","enrollment":78},{"nctId":"NCT03359837","phase":"PHASE4","title":"Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":384},{"nctId":"NCT04847219","phase":"NA","title":"Efficacy and Safety of Premixed Insulin Treatment in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2019-10-09","conditions":"Type 2 Diabetes","enrollment":239},{"nctId":"NCT03430284","phase":"PHASE4","title":"Multifactorial Intervention on Diabetes (MIDiab Study)","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2018-04-01","conditions":"Diabetes Mellitus, Type 2","enrollment":6300},{"nctId":"NCT01293396","phase":"PHASE4","title":"Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2010-06","conditions":"Type 2 Diabetes","enrollment":20},{"nctId":"NCT04739241","phase":"PHASE4","title":"Premixed vs Basal Bolus Insulin Therapy in Older Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Consorci Sanitari Integral","startDate":"2014-01-24","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":60},{"nctId":"NCT04726657","phase":"NA","title":"Comparison of Two Biphasic Insulin Regimens","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2016-01-18","conditions":"Diabetes Mellitus, Type 2","enrollment":36},{"nctId":"NCT04726631","phase":"NA","title":"Insulin in Treatment of Diabetes Mellitus With Pregnancy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-01-01","conditions":"Diabetes","enrollment":110},{"nctId":"NCT04654676","phase":"PHASE4","title":"DPP4 Inhibitor on Glycemic Variability","status":"COMPLETED","sponsor":"University Malaysia Sarawak","startDate":"2018-09-15","conditions":"Diabetes Mellitus, Type 2","enrollment":12},{"nctId":"NCT01957930","phase":"NA","title":"Intensive Insulin Treatment and Ischemic Foot Ulcer","status":"COMPLETED","sponsor":"Karolinska Institutet","startDate":"1984-01","conditions":"Ischemic Foot Ulcer","enrollment":91},{"nctId":"NCT03881995","phase":"PHASE4","title":"Effects of Insulin Glargine and Lixisenatide on the Brain","status":"TERMINATED","sponsor":"University Hospital Tuebingen","startDate":"2019-03-18","conditions":"Diabetes Mellitus, Type 2","enrollment":1},{"nctId":"NCT00736515","phase":"PHASE4","title":"Study of Combination Therapy of Gliclazide MR and Basal Insulin Versus Insulin Monotherapy to Treat Type 2 Diabetes","status":"COMPLETED","sponsor":"Servier (Tianjin) Pharmaceutical Co. LTD.","startDate":"2008-10","conditions":"Type 2 Diabetes","enrollment":160},{"nctId":"NCT04022291","phase":"PHASE1","title":"Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30","status":"COMPLETED","sponsor":"Biocon Limited","startDate":"2019-06-15","conditions":"Healthy Volunteer","enrollment":78},{"nctId":"NCT02987751","phase":"PHASE4","title":"A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals","startDate":"2016-12-29","conditions":"Type2 Diabetes","enrollment":200},{"nctId":"NCT01009580","phase":"PHASE3","title":"Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2009-11-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":447},{"nctId":"NCT02467920","phase":"PHASE4","title":"Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM","status":"COMPLETED","sponsor":"Huazhong University of Science and Technology","startDate":"2015-08","conditions":"Type 2 Diabetes Mellitus","enrollment":349},{"nctId":"NCT02219750","phase":"PHASE4","title":"Comparison of Premixed Insulin With Basal-plus Insulin in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Mackay Memorial Hospital","startDate":"2013-08","conditions":"Diabetes","enrollment":181},{"nctId":"NCT03513055","phase":"NA","title":"Influence of Injection Technique of Premixed Insulin on Glucose Excursion in Type 2 Diabetes Mellitus","status":"UNKNOWN","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2018-05-07","conditions":"Type2 Diabetes Mellitus","enrollment":60},{"nctId":"NCT01572740","phase":"PHASE3","title":"Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-04-05","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":257},{"nctId":"NCT03320031","phase":"PHASE4","title":"A Study of Adding Linagliptin to Control Glycemic Variability and HbA1c in Peritoneal Dialysis Patients With Type 2 Diabetes(PDPD) With Premixed Insulin Therapy","status":"UNKNOWN","sponsor":"Yanbing Li","startDate":"2017-06-03","conditions":"Type 2 Diabetes Mellitus, Peritoneal Dialysis","enrollment":232},{"nctId":"NCT02104804","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of Saxagliptin Added to Insulin Monotherapy or to Insulin Combined With Metformin in Chinese Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-05-07","conditions":"Type 2 Diabetes Mellitus","enrollment":953},{"nctId":"NCT02168491","phase":"PHASE3","title":"Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal Insulin","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2014-11","conditions":"Type 2 Diabetes Mellitus","enrollment":10},{"nctId":"NCT01536626","phase":"","title":"Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2006-06-09","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":211},{"nctId":"NCT01618214","phase":"PHASE4","title":"Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2012-06","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":344},{"nctId":"NCT01720303","phase":"PHASE4","title":"Efficacy and Safety of Repaglinide Combined With Insulin in Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2002-09-19","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":159},{"nctId":"NCT03018665","phase":"PHASE4","title":"A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese","status":"UNKNOWN","sponsor":"The First Hospital of Jilin University","startDate":"2017-02","conditions":"Diabetes Mellitus, Type 2","enrollment":200},{"nctId":"NCT01235819","phase":"PHASE4","title":"Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Command Hospital, India","startDate":"2010-11","conditions":"Type 1 Diabetes","enrollment":20},{"nctId":"NCT02632032","phase":"NA","title":"Impact of a Diabetes Camp on Glycemic Control Among Children and Adolescents Living With Type 1 Diabetes in Cameroon","status":"COMPLETED","sponsor":"Yaounde Central Hospital","startDate":"2013-07","conditions":"Type 1 Diabetes","enrollment":46},{"nctId":"NCT02587741","phase":"EARLY_PHASE1","title":"Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-07","conditions":"Diabetic Retinopathy","enrollment":600},{"nctId":"NCT00434954","phase":"PHASE3","title":"Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2007-02","conditions":"Type 2 Diabetes Mellitus","enrollment":494},{"nctId":"NCT02333851","phase":"PHASE4","title":"Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)","status":"TERMINATED","sponsor":"Hospital Universitario Central de Asturias","startDate":"2013-06","conditions":"Type 2 Diabetes Mellitus","enrollment":72},{"nctId":"NCT00309244","phase":"PHASE3","title":"Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2006-02","conditions":"Diabetes Type 2","enrollment":677},{"nctId":"NCT01175811","phase":"PHASE4","title":"A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2011-02","conditions":"Diabetes Mellitus, Type 2","enrollment":402},{"nctId":"NCT01147627","phase":"NA","title":"Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2010-08","conditions":"Diabetes Mellitus, Type 2, Newly Diagnosed","enrollment":416},{"nctId":"NCT01079364","phase":"PHASE4","title":"Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use Setting","status":"TERMINATED","sponsor":"Sanofi","startDate":"2010-01","conditions":"Diabetes Mellitus, Type 2","enrollment":52},{"nctId":"NCT01121835","phase":"PHASE4","title":"Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-02","conditions":"Diabetes Mellitus, Type 2","enrollment":934},{"nctId":"NCT01627509","phase":"","title":"Comparison of Two Insulin Regimens in Optimally-controlled Patients With DM2.","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2012-05","conditions":"Diabetes Mellitus 2 Type","enrollment":40},{"nctId":"NCT00664534","phase":"PHASE4","title":"Pre-Mix Insulin Lispro Treatment for Type 2 Diabetes Patients Who Consume a Light Breakfast","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2008-04","conditions":"Diabetes Mellitus, Type 2","enrollment":344},{"nctId":"NCT00384085","phase":"PHASE4","title":"Insulin Glargine \"All to Target\" Trial","status":"COMPLETED","sponsor":"Sanofi","startDate":"2006-05","conditions":"Diabetes Mellitus, Type 2","enrollment":588},{"nctId":"NCT00693771","phase":"PHASE4","title":"Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2008-04","conditions":"Diabetes Mellitus, Type 2","enrollment":313},{"nctId":"NCT00377858","phase":"PHASE4","title":"Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX)","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-08","conditions":"Diabetes Mellitus, Type 2","enrollment":484},{"nctId":"NCT00783744","phase":"PHASE3","title":"Insulin Glargine Combination Therapies in Type II Diabetics","status":"COMPLETED","sponsor":"Sanofi","startDate":"2001-12","conditions":"Diabetes Mellitus, Type 2","enrollment":375},{"nctId":"NCT00369148","phase":"PHASE4","title":"Combination of Glinides With Premixed Insulin","status":"COMPLETED","sponsor":"Keio University","startDate":"2004-07","conditions":"Type 2 Diabets Mellitus","enrollment":60}],"_emaApprovals":[],"_faersSignals":[{"count":5,"reaction":"ACUTE KIDNEY INJURY"},{"count":4,"reaction":"URAEMIC ENCEPHALOPATHY"},{"count":3,"reaction":"URINARY RETENTION"},{"count":2,"reaction":"BASAL CELL CARCINOMA"},{"count":2,"reaction":"BOWEN'S DISEASE"},{"count":2,"reaction":"HYPERTENSION"},{"count":1,"reaction":"ASTHENIA"},{"count":1,"reaction":"CHEST PAIN"},{"count":1,"reaction":"DEPRESSION"},{"count":1,"reaction":"DIABETES MELLITUS"}],"_approvalHistory":[],"publicationCount":468,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Novolog Mix 70/30","Biphasic Aspart 30"],"phase":"marketed","status":"active","brandName":"Premixed insulin","genericName":"Premixed insulin","companyName":"Peking University People's Hospital","companyId":"peking-university-people-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Premixed insulin combines rapid-acting and intermediate-acting insulin to provide both immediate and sustained blood glucose control. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}